![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Hänel, Gerulf 
ORCID: https://orcid.org/0000-0003-4685-6499; Schöne, Anne; Neumann, Anne-Sophie; Nixdorf, Daniel ORCID: https://orcid.org/0000-0003-1612-9952; Philipp, Nora ORCID: https://orcid.org/0000-0002-3918-7795; Sponheimer, Monika; Leutbecher, Alexandra; Emhardt, Alica-Joana; Magno, Giulia; Bücklein, Veit ORCID: https://orcid.org/0000-0001-7391-7280; Eckmann, Jan; Dunshee, Diana; Kramar, Vesna; Korfi, Koorosh; Colombetti, Sara; Umaña, Pablo ORCID: https://orcid.org/0000-0001-8206-2771; Klein, Christian ORCID: https://orcid.org/0000-0001-7594-7280 und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2024):
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.
In: Leukemia, Nr. 38: S. 348-402
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-4685-6499; Schöne, Anne; Neumann, Anne-Sophie; Nixdorf, Daniel ORCID: https://orcid.org/0000-0003-1612-9952; Philipp, Nora ORCID: https://orcid.org/0000-0002-3918-7795; Sponheimer, Monika; Leutbecher, Alexandra; Emhardt, Alica-Joana; Magno, Giulia; Bücklein, Veit ORCID: https://orcid.org/0000-0001-7391-7280; Eckmann, Jan; Dunshee, Diana; Kramar, Vesna; Korfi, Koorosh; Colombetti, Sara; Umaña, Pablo ORCID: https://orcid.org/0000-0001-8206-2771; Klein, Christian ORCID: https://orcid.org/0000-0001-7594-7280 und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2024):
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.
In: Leukemia, Nr. 38: S. 348-402
[PDF, 1MB]
Marcinek, Anetta; Brauchle, Bettina; Rohrbacher, Lisa; Hänel, Gerulf; Philipp, Nora; Märkl, Florian; Strzalkowski, Thaddäus; Lacher, Sonja M.; Udiljak, Dragica; Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957; Theurich, Sebastian; Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673; Kischel, Roman; James, John R.; Bücklein, Veit L. und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
In: Cancer Immunology, Immunotherapy, Bd. 72, Nr. 7: S. 2499-2512
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-5139-4957; Theurich, Sebastian; Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673; Kischel, Roman; James, John R.; Bücklein, Veit L. und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
In: Cancer Immunology, Immunotherapy, Bd. 72, Nr. 7: S. 2499-2512
[PDF, 1MB]
Köhnke, Thomas; Liu, Xilong; Haubner, Sascha; Bücklein, Veit; Hänel, Gerulf; Krupka, Christina; Solis-Mezarino, Victor; Herzog, Franz und Subklewe, Marion
(10. Juni 2022):
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
In: Biomarker Research, Bd. 10
[PDF, 5MB]
Philipp, Nora; Kazerani, Maryam; Nicholls, Alyssa; Vick, Binje; Wulf, Jan; Straub, Tobias; Scheurer, Michaela; Muth, Amelie; Hänel, Gerulf; Nixdorf, Daniel; Sponheimer, Monika; Ohlmeyer, Malte; Lacher, Sonja M.; Brauchle, Bettina; Marcinek, Anetta; Rohrbacher, Lisa; Leutbecher, Alexandra; Rejeski, Kai; Weigert, Oliver; Bergwelt-Baildon, Michael von; Theurich, Sebastian; Kischel, Roman; Jeremias, Irmela; Bücklein, Veit und Subklewe, Marion
(2022):
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals.
In: Blood, Bd. 140, Nr. 10: S. 1104-1118
Hänel, Gerulf; Angerer, Caroline; Petry, Katja; Lichtenegger, Felix S. und Subklewe, Marion
(2021):
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.
In: Cancer immunology, immunotherapy : CII
[PDF, 3MB]